Huaqin Pan | Infection Microbiology | Best Researcher Award

Published on by Popular Scientist

Assoc. Prof. Dr. Huaqin Pan | Infection Microbiology | Best Researcher Award

Chief at Zhongnan Hospital of Wuhan University, China

Dr. Huaqin Pan is a Chief Physician and Associate Professor at the Department of Transplantation Intensive Care Unit, Zhongnan Hospital of Wuhan University, China. He holds a Ph.D. and M.D. in Gastroenterology from Wuhan University School of Medicine, and a B.S. in Laboratory Medicine from Hubei University of Chinese Medicine.

Profile:

🎓 Education:

  • Ph.D. in Gastroenterology – Wuhan University (2015)

  • M.D. in Gastroenterology – Wuhan University (2012)

  • B.S. in Laboratory Medicine – Hubei University of Chinese Medicine (2009)

🔬 Research Focus:

  • Inflammatory Bowel Disease (IBD)

  • Sepsis, Asthma, Colitis, and COVID-19

  • Gut microbiota & fecal microbiota transplantation (FMT)

  • Immunomodulation via MD-1, RP105, and TLR4/NF-ÎşB signaling

🧪 Key Skills & Techniques:

  • Animal disease models (DSS-colitis, asthma, sepsis)

  • Flow cytometry, ELISA, PCR, Immunohistochemistry

  • Cell culture, cytokine profiling, vector construction

  • Metabolomics, bioinformatics, statistical modeling (R, SPSS)

đź“š Publications & Impact:

  • 50+ peer-reviewed papers

  • Published in Am J Physiol, Front Neurol, World J Gastroenterol, Cell Death Discov, etc.

  • Frequent corresponding & co-first author

  • COVID-19, colitis, and sepsis research widely cited

đź’ˇ Funded Projects (as PI):

  • NSFC Grant on MD-1 and colitis

  • FMT & gut microbiome in ICU patients

  • RP105/MD-1 role in sepsis pathogenesis

🏆 Honors & Presentations:

  • Poster presenter at AOCC 2016 (Kyoto, Japan)

  • DDW 2019 (San Diego, USA)

  • Chinese Medical Association COVID-19 forum (2021)

🧑‍⚕️ Clinical Roles:

  • Chief Physician (2023–Present)

  • Former Associate Chief Physician & Mentor (2020–2023)

  • Over a decade of experience in intensive care and transplant medicine

🌍 Memberships & Editorial Roles:

  • Editorial board: World Journal of Experimental Medicine

  • Peer reviewer for World J Gastroenterol & Clinical Cases

  • Member: Chinese Medical Association (Transplantation Infection Group)

📊 Citation Metrics – Dr. Huaqin Pan, M.D., Ph.D.

  • Total Citations: 759

  • Citing Documents: 757

  • Total Publications (Indexed): 29

  • h-index: 11

Publication Top Notes:

  • Effect of antiplatelet therapy after COVID-19 diagnosis: A systematic review with meta-analysis and trial sequential analysis
    PLoS ONE, 2024. DOI: 10.1371/journal.pone.0297628

  • Comparative effectiveness of treatments for recurrent Clostridioides difficile infection: A network meta-analysis of randomized controlled trials
    Frontiers in Pharmacology, 2024. DOI: 10.3389/fphar.2024.1430724

  • Identification of predictive markers of Pneumocystis jirovecii pneumonia in kidney transplant recipients
    Transplant Immunology, 2024. DOI: 10.1016/j.trim.2024.102074

  • Hemophagocytic lymphohistiocytosis associated with synergistic defects of AP3B1 and ATM genes: A case report and literature review
    Journal of Clinical Medicine, 2023. DOI: 10.3390/jcm12010095

  • Research advances of Toll-like receptor 4 in sepsis
    Medical Journal of Wuhan University, 2023. DOI: 10.14188/j.1671-8852.2021.0891

  • Screening of potential key ferroptosis-related genes in chronic obstructive pulmonary disease
    International Journal of COPD, 2023. DOI: 10.2147/COPD.S422835

  • Washed microbiota transplantation for Clostridioides difficile infection: A national multicenter real-world study
    Journal of Digestive Diseases, 2023. DOI: 10.1111/1751-2980.13227

  • Pulmonary fat embolism syndrome: A case report and literature review
    Iranian Red Crescent Medical Journal, 2023. DOI: 10.32592/ircmj.2023.25.7.2600

  • Effect of therapeutic versus prophylactic anticoagulation therapy on clinical outcomes in COVID-19 patients: A systematic review with updated meta-analysis
    Thrombosis Journal, 2022. DOI: 10.1186/s12959-022-00408-9

  • Sera metabolomics characterization of patients at different stages in Wuhan identifies critical biomarkers of COVID-19
    Frontiers in Cellular and Infection Microbiology, 2022. DOI: 10.3389/fcimb.2022.882661

  • Aberrant cytokine expression in COVID-19 patients: Associations between cytokines and disease severity
    Cytokine, 2021. DOI: 10.1016/j.cyto.2021.155523

  • Case report: The coronavirus disease 2019 (COVID-19) pneumonia with multiple thromboembolism
    Frontiers in Neurology, 2021. DOI: 10.3389/fneur.2020.625272

  • COVID-19 and its effects on the digestive system
    World Journal of Gastroenterology, 2021. DOI: 10.3748/wjg.v27.i24.3502

  • Serum uric acid concentrations and risk of adverse outcomes in patients with COVID-19
    Frontiers in Endocrinology, 2021. DOI: 10.3389/fendo.2021.633767